BIO Asia-Taiwan 2026
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to international partnerships, licensing, clinical development and a bigger role in the global biomedical ecosystem.
BioWorld Analysis and data insight Conferences Regulatory BIO Asia-Taiwan Immune Infection Respiratory Cell therapy Gene therapy Asia-Pacific Trade